Posted at 22 Jul, 14:15h in Press Release, Uncategorized by adialpharma 0 Comments 0 Likes Share Adial Pharmaceuticals Receives European Medicines Agency (EMA) Agreement on the Pediatric Investigation Plan (PIP) for AD04 in Alcohol Use Disorder
Sorry, the comment form is closed at this time.